WHY WORK WITH INNOPHARMA TECHNOLOGY?

Collaboration and risk management 

If you're considering implementing an advanced data platform to optimise your pharma development and manufacturing, our pharma specialists and process engineers will work with you to shape the best technology response. With more insights delivered faster and with ever-increasing automation, we’ll help you achieve the quality, control, efficiency and sustainability you need.

SMARTX

Changing Timescales

Accelerated Process Development 

Our SmartX platform provides a fast and clear view of the critical inputs affecting your process.

Refine input parameters quickly and progress with process development in far shorter timescales.


Discover More
eyecon2

Increasing Insights 

Simplifying Real-Time Process Data

Our SmartX platform, drawing on information from Innopharma Technology PAT sensors and other sources, organises data into simple to access, actionable insights.

Adapt the factors impacting on your drug development and manufacturing armed with the process intelligence you need.


Discover More
eyecon2

Progressing to Pharma 4.0

Automating Analysis and Control

We bring complete PAT and process sensor information together and make it view-able through our SmartX dashboard.

Data is aggregated, analysed and visualised smarter and faster, and control decisions are automated. Giving you efficiencies and competitive advantage. 


Discover More

0

focus to simplify

real-time process intelligence for faster, smarter pharma development and manufacturing.


0

years of successful

PAT imaging and spectroscopic solutions driven by a team of expert engineers and scientists.


0m

Research & Innovation Funding

from FP7, EU Horizon 2020 & Enterprise Ireland supporting our unique R&D projects.


0

countries worldwide

to collaborate with industry and academia to progress the future of pharma manufacturing.


SmartX

SmartX

 

The controller within SmartXTM can utilise real-time particle size and moisture content data, combined with fluid bed granulation process data, to make real-time, automated process control decisions.


Read More

Multieye2

 

Integration of Multieye2TM into a fluid bed granulation process, allowed researchers at Technological University Dublin to monitor the moisture trend of liquid addition and drying in real-time


Read More

MULTIEYE2
EYECON2

Eyecon2

 

Integration of Eyecon2TM into Alkermes’ centrifugal spheronisation manufacturing processes ensured a more robust analytical method and an 8% increase in yield.


Read More

Testimonials

The Eyecon is outstanding in measuring in-process particle size during the granulation and particle coating processes. We also integrated this technology into our control systems, as part of a Process Analytical Technology package desired by some of our clients.

testimonial-img

Ed Godek | Process Technology Manager | Glatt Air Techniques, Inc.

While using the Multieye to measure roller compaction ribbons, we observed an excellent correlation between the NIR spectra and off-line density results.

testimonial-img

Abina Crean | Lecturer in Pharmaceutics | University College Cork

Eyecon₂ with its automated high-speed image analysis is implemented to accurately predict the process end-point with fast objective PSD data, supported by particle images, to significantly improve process optimisation and control.

testimonial-img

Thomas Hoffmeir | Head of Business Unit - Process Technology Pharma | Glatt GmbH

Using the Multieye we have the capability to beautifully monitor the moisture trend in real-time, during the liquid addition and drying process in a fluid bed granulation process.

testimonial-img

Denisio Togashi | Post-Doctoral Researcher | Dublin Institute of Technology

More and more high-end Chinese pharmaceutical manufacturers are aware of and actively seeking to implement QbD principals into their manufacturing processes. Implementation of Eyecon₂ optimises FBP design and subsequently enables increased process understanding.

testimonial-img

Arthur Rong | Vice Manager - Oral Solid Dosage | Austar

Before we had any PAT tools, the process was like a black box to us. We put something in and get something out without knowing what happened inside. Now, we have an ‘Eye’ to look inside that black box and see what’s going on in there.

testimonial-img

Deron HE | General Manager - Smart Manufacturing | Chanse Technology (Jiangsu) Inc.


card-img card-img

News

Wednesday 16 June

Quick Guide to Particle Size Distribution

Particle size distribution (PSD) is the means of measuring the number of particles by mass and size to calculate a size and mass range. D-values can be thought of as a mass division diameter. It is the diameter which, when all particles in a sample are arranged in order of ascending mass, divides the sample's mass into specified percentages.

Read more
card-img card-img

News

Wednesday 14 April

What is Power BI and what is it used for?

What is Power BI and what is it used for? Power BI is an easy-to-use business intelligence platform by Microsoft which collects and visualizes data.

Read more
  • How to Establish a Particle Size Specification for OSD Control

    Particle variability, particularly particle size distribution (PSD), can substantially impact the flowability, blend uniformity, compressibility, dissolution rate and bioavailability of OSD. The result of these factors ultimately impacts the safety, efficacy, and quality of drugs. Controlling and monitoring PSD in your process is among the highest priority in the pharmaceutical industry.

    Read more
  • A Guide to Mulitparticulates and the Developmental Role of PAT

    Multiple unit dosage forms (MUDF), also known as multiparticluates provide benefits in formulation flexibility such as immediate-release, delayed-release and sustained-release from a single dosage form, simply by changing the coating properties. This guide demonstrates the benefits of using PAT for multiparticulate development and control.

    Read more
  • A COVID-19 Vaccine Is Coming, but Can We Make It Safe, Fast and Effective Enough?

    2021 may be the year we see promising vaccines gain approval and enter production, but do we have the manufacturing capability to rapidly scale production to meet feverish global demand? With SmartX, we can.

    Read more